- Home
- Management of Degenerative MR With TEER: An Evidence-based Guide
Management of Degenerative MR With TEER: An Evidence-based Guide
- Intervention
- Structural Heart Disease
Available Credit:
- 0.75
Course Published On:
Course Expiry Date:
Overview
Gain expert-led insights into transcatheter edge-to-edge repair (TEER) for degenerative mitral regurgitation (DMR) through this CME-accredited online course, following the live interactive symposium at Transcatheter Interventions Online 2025 (TIO).
Explore patient selection, device-specific design and procedural techniques through engaging case-based discussions, led by Dr Tarun Chakravarty (Cedars-Sinai Heart Institute, US), Dr Firas Zahr (Oregon Health and Science University, US) and Dr Tom Cahill (John Radcliffe Hospital, UK). The expert faculty highlight the unmet clinical need in the US, supported by real-world data and outcomes.
Support Statement
This symposium is supported by an unrestricted educational grant from Edwards Lifesciences.
Disclosure
In compliance with ACCME guidelines, all speakers/chairpersons participating in this programme have disclosed or indicated potential conflicts of interest which might cause a bias in the presentations.
The Organising Committee/Course Director is responsible for ensuring that all potential conflicts of interest relevant to the event are declared to the audience prior to the CME activities.
Instruction to Participants
There is no fee for taking part in this online learning activity.
Activities are designed to be completed within 45 minutes and must be completed by the registered user. Physicians should only claim credits for time spent on the activity. To successfully earn credit, participants must complete the activity in full in the indicated time frame.
To complete the course and claim certification participants must:
- Read the course outline information supplied and complete pre-test questions if supplied prior to starting the activity. Users must read and study the activity in its entirety before completing the post-test questions.
- Your results will be automatically saved and if a pass score is achieved (where applicable), you may be eligible to claim credit for the activity and receive a certificate of completion.
Terms & Conditions
Radcliffe Medical Education requires contributors to our CME programmes to disclose any relevant financial relationships that have occurred within the past 24 months that could create a conflict of interest. These will be identified in the faculty section if applicable.
The activity, 'Management of Degenerative MR With TEER: An Evidence-based Guide', has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of PeerPoint Medical Education Institute and Radcliffe Medical Education. PeerPoint Medical Education Institute is accredited by the ACCME to provide continuing medical education for physicians.
PeerPoint Medical Education Institute designates the live and enduring format for this educational activity for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Live activity date: April 12, 2025
Enduring activity dates: April 30, 2025 – April 30, 2026
Privacy Policy:
PeerPoint Medical Education Institute, LLC (“PeerPoint”) is committed to protecting the privacy of information provided by and about the users of our websites/platforms. PeerPoint respects your privacy and will not share any such information without your consent, except as described in this privacy policy. This policy outlines what information we may collect, how and why we use it, with whom it may be shared, your rights regarding your information, how to contact us with privacy concerns or requests, and the measures we take to safeguard against unauthorized access or misuse of your data.
About This Privacy Policy
This privacy policy applies only to information that identifies you or could identify you when combined with other available data (“personal data”), and that you either submit to PeerPoint Medical Education Institute, LLC ("PeerPoint") in connection with your use of PeerPoint websites/platforms or upon registration related to PeerPoint systems and services. It may also apply to personal data collected from other sources, as outlined in this policy.
By using PeerPoint websites/platforms and/or receiving our services, you consent to the collection, use, disclosure, and transfer of your personal data as described in this privacy policy.
This policy does not apply to any personal data you submit directly to third-party websites or services not operated by PeerPoint, even if accessed through PeerPoint websites. We encourage you to review the privacy policies of any external sites you visit, as PeerPoint is not responsible for how those entities handle your personal data.
Unless otherwise noted, PeerPoint acts as a data controller (as defined under the EU General Data Protection Regulation), meaning we determine how and why your personal data is processed.
To request account deactivation or correction of your personal data, contact us at sales@peerpt.com.
Note: Certain information may be retained as needed for legal or administrative reason
Target Audience
- Interventional Cardiologists
- Surgeons with an interest in transcatheter treatment strategies for coronary and structural heart disease
- Interventional Cardiology Nurses
Learning Objectives
Upon completion of this activity, participants will be able to:
- Identify suitable patients for transcatheter repair over other treatments
- Recall long-term clinical outcomes for TEER in patients with DMR
- Select TEER devices based on design features and clinical data
- Review TEER implantation techniques
Module |
Title |
Duration |
Speakers |
|---|---|---|---|
| Part 1 | Welcome and Introduction | 2m 42s | Tarun Chakravarty Firas Zahr Tom Cahill |
| Part 2 | Transcatheter Repair: Selection in Degenerative MR | 9m 7s | Tarun Chakravarty |
| Part 3 | Making Evidence-based Decisions in TEER – Insights From Recent Clinical Data | 9m 24s | Firas Zahr |
| Part 4 | Technical Considerations for TEER in DMR Patients | 10m | Tom Cahill |
| Part 5 | Panel Discussion and Q&A | 17m 25s | Tarun Chakravarty Firas Zahr Tom Cahill |
Making Evidence-based Decisions in TEER – Insights From Recent Clinical Data
Duration: 9m 24s
Speakers: Firas Zahr
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of PeerPoint Medical Education Institute and Radcliffe Medical Education. PeerPoint Medical Education Institute is accredited by the ACCME to provide continuing medical education for physicians.
PeerPoint Medical Education Institute designates the live and enduring format for this educational activity for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Enduring activity dates: April 30, 2025 – April 30, 2026
Related Courses
- 1.00
Published:
Learning objectives
- Recall the critical steps in lesion preparation and on post dilation to optimise valve implantation when needed
- Recognise the technical considerations in precise valve positioning and deployment for larger annuli patients
- Explore the long-term implications of index procedure optimisation on patient management and outcomes
- Engage with an expert operator through a live case demonstration and interactive discussion
- 1.00
Published:
Learning objectives
- Evaluate the factors influencing coronary access in different valve designs
- Formulate strategies to optimise coronary access based on valve characteristics
- Evaluate the role of valve design in reducing pacemaker implantation rates and enhancing future coronary access
- Learn the step-by-step process for achieving optimum implant depth during TAVI
- Apply guidelines and best practices for achieving and confirming optimum implant depth in TAVI procedures
- 1.00
Published:
Learning objectives
- Describe the practical implications of TAVI in the context of coronary artery disease, atrioventricular valve disease and transcatheter heart valve degeneration
- Select appropriate tools for calcified coronary artery disease, including mechanical circulatory support and invasive imaging techniques
- Understand coronary physiology, novel recanalization and goal-oriented planning for chronic total occlusion
- Evaluate the role of novel oral anticoagulants in transcatheter aortic valve implantation
- Discuss the need for gender-specific trials and renal denervation